ART Advanced Research Technologies Inc. Concludes Agreement With GE Healthcare For The Distribution Of The Fenestra'TM' Line Of Molecular Imaging Contrast Products In Japan
MONTREAL, QUEBEC--(CCNMatthews - July 18, 2006) - ART Advanced Research Technologies Inc. (ART) (TSX:ARA) has concluded an agreement with GE Healthcare Bio-Sciences KK (BSKK), Japan's life sciences unit within GE Healthcare of General Electric Company under which it will act as exclusive distributor in Japan for ART's FenestraTM line of molecular imaging contrast products. Terms were not disclosed.